Temporary trends of invasive uterine cancer in women between 20 and 39 years. Manizales, Colombia. 2003-2018
DOI:
https://doi.org/10.22517/25395203.24621Keywords:
Cervical cancer, Adolescent, Young adult, Epidemiology, trendsAbstract
Objective: This article analyzes the invasive uterine cancer occurrences in women between 20 and 39 years old in Manizales, Colombia, 2003-2018.
Materials and methods: Observational, descriptive, retrospective, population-based study. Temporary trends of occurrences were evaluated (as referring to Population Segi, per 100,000 women / year) by using the Joinpoint regression (Joint Point Regression Program v. 4.7.0.0 of the National Cancer Institute of the USA), in order to estimate annual percentage changes and number of years of significant variation in trends.
Results: The study was carried out with a total of 116 patients, whose average age at the time of diagnosis was 33.7 years. Only 3 invasive cancer cases were found in women between the ages of 20 and 25. The greatest number of cases occurred in the group of women between 35 and 39 years old. The most frequent histological type was squamous cell carcinoma. 45.6% of cases were diagnosed in early stages. The Average Annual Percentage Change calculated using the Joinpoint regression model showed a 7.9% decrease in the incidence rate between 2003 and 2018, with a breaking point in 2010.
Conclusions: Cervical cancer in Manizales is infrequent in women under the age of 25; and, for ages between 20 and 39, it has shown a tendency to decrease over time, particularly from 2010 onwards.
Downloads
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. 2019;393(10167):169–82.
Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, de Lima Lopes G Jr, Dizon DS, Schmeler KM, Del Carmen M, Randall TC, Nogueira-Rodrigues A, de Carvalho Calabrich AF, St Louis J, Vail CM, Goss PE. Cervical cancer control in Latin America: A call to action. Cancer. 2016;122(4):502-14. https://doi.org/10.1002/cncr.29813
International Agency for Research on Cancer. Colombia. Source: Globocan. internet2020 citado el 15 de marzo 2020. Disponible en: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf
Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer J Clin. 2019;69(1):7–34.
Muñoz N, Bravo LE. Epidemiology of cervical cancer in Colombia. Salud Publica Mex. 2014;56(5):431–9.
Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, et al. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Prev Med.2017;98:5–14.
Vidal C, Hoffmeister L, Biagini L. Tendencia de la mortalidad por cáncer de cuello uterino en Chile: aplicación de modelos de regresión joinpoint. Rev panam salud pública. 2013;33(6):407–13.
Pardo C, de Vries E. Breast and cervical cancer survival at instituto nacional de cancerología, Colombia. Colomb Med. 2018;49(1):102–8.
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147–72. https://doi.org/10.3322/caac.21139
Practice Bulletin No. 157: Cervical Cancer Screening and Prevention. Obstet Gynecol. 2016;127(1):e1–20. https://doi.org/10.1097/AOG.0000000000001263
Ministerio de Salud y Protección Social. Guía de práctica clínica (GPC) para la detección y manejo de lesiones precancerosas de cuello uterino. Guía completa. Colombia internet 2014 citado el 15 de marzo 2020. Disponible en: https://www.cancer.gov.co/Gu%C3%ADas-y-Protocolos/Gu%C3%ADas-de-Practica-clinica/LPC-Guia-profesionales.pdf
Benard VB, Watson M, Castle PE, Saraiya M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol. 2012;120(5):1117–23.
Ruiz R, Serrano M, Ruiz EF, Mantilla R, Valdivieso N, Olivera M, et al. Clinical-pathological features and survival in young women with cervical cancer: A retrospective analysis from the instituto nacional de enfermedades neoplÁsicas. Rev Peru Med Exp Salud Publica. 2017;34(2):218–27.
Moon EK, Oh CM, Won YJ, Lee JK, Jung KW, Cho H, et al. Trends and age-period-cohort effects on the incidence and mortality rate of cervical cancer in Korea. Cancer Res Treat. 2017;49(2):526–33.
Pelkofski E, Stine J, Wages NA, Gehrig PA, Kim KH, Cantrell LA. Cervical Cancer in Women Aged 35 Years and Younger. Clin Ther. 2016;38(3):459–66.
Patel A, Galaal K, Burnley C, Faulkner K, Martin-Hirsch P, Bland MJ, et al. Cervical cancer incidence in young women: A historical and geographic controlled UK regional population study. Br J Cancer. 2012;106(11):1753–9.
Utada M, Chernyavskiy P, Lee WJ, Franceschi S, Sauvaget C, de Gonzalez AB, et al. Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012. Int J Cancer. 2019;144(9):2144–52.
Kong Y, Zong L, Yang J, Wu M, Xiang Y. Cervical cancer in women aged 25 years or younger: A retrospective study. Cancer Manag Res. 2019;11:2051–8.
Berkowitz RS, Ehrmann RL, Lavizzo-Mourey R, Knapp RC. Invasive cervical carcinoma in young women. Gynecol Oncol. 1979;8(3):311–6.
Elliott PM, Tattersall MH, Coppleson M, Russell P, Wong F, Coates AS, et al. Changing character of cervical cancer in young women. BMJ. 1989;298(6669):288–90.
Sasieni P, Castanon A. Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24. J Med Screen. 2012;19(3):127–32.
Caro-Porras N. Análisis epidemiológico de mujeres con carcinoma epidermoide de cérvix, 2007-2015. Acta méd costarric. 2017;59(1):22–7.
Herbert A, Holdsworth G, Kubba AA. Cervical screening: Why young women should be encouraged to be screened. J Fam Plan Reprod Heal Care. 2008;34(1):21–5.
Frumovitz MD. Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. 2020.
Baldur-Felskov B, Munk C, Nielsen TSS, Dehlendorff C, Kirschner B, Junge J, et al. Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997–2012. Cancer Causes Control. 2015;26(8):1105–16.
Ocampo Ramírez, J. Análisis costo efectividad de estrategias de atención para cáncer de cuello uterino: un estudio de caso para el departamento de Caldas. [Internet]. Montevideo, Uruguay: Universidad de la República ; 2018-07-05. [citado diciembre 2020]. Universidad Nacional de Colombia, Sede Medellín :Facultad de Ciencias Humanas y Económicas, Escuela de Economía.
Downloads
-
Vistas(Views): 477
- PDF (Español (España)) Descargas(Downloads): 342
- PDF Descargas(Downloads): 115
Published
How to Cite
Issue
Section
License
Cesión de derechos y tratamiento de datos
La aceptación de un artículo para su publicación en la Revista Médica de Risaralda implica la cesión de los derechos de impresión y reproducción, por cualquier forma y medio, del autor a favor de Facultad de Ciencias de la Salud de la Universidad Tecnológica de Pereira. 1995-2018. Todos los derechos reservados ®
por parte de los autores para obtener el permiso de reproducción de sus contribuciones. La reproducción total o parcial de los trabajos aparecidos en la Revista Médica de Risaralda, debe hacerse citando la procedencia, en caso contrario, se viola los derechos reservados.
Asimismo, se entiende que los conceptos y opiniones expresados en cada trabajo son de la exclusiva responsabilidad del autor, sin responsabilizarse ni solidarizarse, necesariamente, ni la redacción, ni la editorial.
Es responsabilidad de los autores poder proporcionar a los lectores interesados copias de los datos en bruto, manuales de procedimiento, puntuaciones y, en general, material experimental relevante.
Asimismo, la Dirección de la revista garantiza el adecuado tratamiento de los datos de carácter personal